The method of data extraction from our electronic chemotherapy prescribing system also underrepresents the number of patients with prostate cancer receiving anti-gonadotropic monotherapy (e.g. LHRH analgoues) as the prescriptions are continued by GPs. This evidence concerns the gene GNRH1 and prostate carcinoma.